Register to attend for only $259 (On-Demand recordings included). Offer expires in:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
The drug development model is in need of a drastic shakeup and COVID-19 has only accelerated this. Now more than ever is there a need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic performance. We’re here to help you improve drug performance, bioavailability, and patient adherence.
This intensive 2-Day program will showcase industry’s latest formulation and delivery technologies for enhancing solubility and maximizing bioavailability. 2021’s Summit will share cutting edge research on the development, characterization and manufacture of formulations that span multiple modalities.
Sign-up for September’s 2021 Global Drug Bioavailability Enhancement Virtual Summit and walk away with over 2 years of new drug formulation and bioavailability enhancement approaches strategies in just 2 short days! Additionally, expand your network further with 100’s of leading drug product development professionals around the world.
Can’t make it this September? Don’t worry, the full virtual event is recorded and available On-Demand also so you and your team won’t miss a thing.
Want to attend but need help to convince your boss?
Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.
- Precision medicine & healthcare delivery
- Rationale formulation design for poorly soluble compounds
- In-vivo – in-vitro correlation
- Solution behavior of amorphous solid dispersions
- Nanosuspension for improving the bioavailability
- Early formulation screening in drug discovery
- 3D printing for biopharmaceuticals
- Enhancing patient adherence via drug delivery
- Innovative strategies around drug / device combinations
2020’s Speakers Included:
Sudhakar Garad, PhD
Global Head of Chemical and Pharmaceutical Profiling
Novartis
Fady Ibrahim, PhD
Team Leader, Senior Principal Scientist
Pfizer
Sune Anderson, PhD
Principal Scientist, Spray Drying
Johnson & Johnson
Tycho Speaker, PhD
Director, Drug Delivery and Biomaterials
Abbvie
Rick Panicucci, PhD
Senior Vice President, CMC
QED Therapeutics
Rakesh Dixit, PhD
President & CEO
Bionavigen
Hamsini Dhoolypala
Senior Associate Scientist, pharmacokinetics and drug metabolism
Amgen
Ajit Narang, PhD
Senior Associate Scientist
Genentech
Eric Munson, PhD
Patrick DeLuca Endowed Professor in Pharmaceutical Technology, Department of Pharmaceutical Sciences
Purdue University
Wen Lin, PhD
Director, Team Lead PBPK
Novartis
Esmaiel Jabbari, PhD
Professor, Chemical Engineering, Biomedical Engineering
University of South Carolina
Calvin Sun, PhD
Associate Department Head, Department of Pharmaceutics
University of Minnesota
Piotr Grodzinski, PhD
Director, NCI Office of Cancer Nanotechnology Research
NCI / NIH
Binfeng Xia, PhD
Senior Manager, Analytical Chemistry, Sanofi
Sanofi
Xiaoling Li, PhD
Associate Dean, Professor & Co-Founder
Triasek
Gerrit Vreeman
Graduate Student
University of Minnesota
30+
100's
of Senior Participants
8+
Networking Segments
16
2020 Sponsors & Exhibitors
Attendance Pricing
Super Early-Bird
Register Before July 30, 2021
Virtual Summit
$259
Early-Bird Pricing
Register Before Aug 13, 2021
Virtual Summit
$309
Standard Pricing
Register August 21, 2021 Onwards
Virtual Summit
$499
Featured Posts
Prodrug Approach for Improving Bioavailability
A prodrug is a medication or compound that metabolizes into a pharmacologically active drug after administration, offering opportunities to optimize the pharmaceutical property to improve bioavailability. Approximately 10% of all marketed drugs worldwide can be...
Applying Nanoparticle Delivery Approaches for Drug Development
Nanomedicines leading the way Nanotechnology offers multiple benefits in treating chronic diseases by site-specific, and target-oriented delivery of medicines. Nanodelivery systems utilized in drug development are very much still relatively new commercial approach....
In Situ Forming Injectable Hydrogel Formulations for Controlled Delivery of Peptides and Proteins
Given the rise of peptide and protein therapeutics in the pharmaceutical landscape, identifying the right delivery strategies that are patient-friendly and can be used over broad dose ranges has always been important considerations for the discovery and development of...
Want to attend but need help to convince your boss?
Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.